IE913167A1 - Therapeutic agents - Google Patents

Therapeutic agents

Info

Publication number
IE913167A1
IE913167A1 IE316791A IE316791A IE913167A1 IE 913167 A1 IE913167 A1 IE 913167A1 IE 316791 A IE316791 A IE 316791A IE 316791 A IE316791 A IE 316791A IE 913167 A1 IE913167 A1 IE 913167A1
Authority
IE
Ireland
Prior art keywords
formula
compound
pharmaceutically acceptable
acceptable salt
methyl
Prior art date
Application number
IE316791A
Other languages
English (en)
Original Assignee
Pfizer Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Ltd filed Critical Pfizer Ltd
Publication of IE913167A1 publication Critical patent/IE913167A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IE316791A 1990-09-11 1991-09-10 Therapeutic agents IE913167A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB909019833A GB9019833D0 (en) 1990-09-11 1990-09-11 Therapeutic agents

Publications (1)

Publication Number Publication Date
IE913167A1 true IE913167A1 (en) 1992-03-11

Family

ID=10682011

Family Applications (1)

Application Number Title Priority Date Filing Date
IE316791A IE913167A1 (en) 1990-09-11 1991-09-10 Therapeutic agents

Country Status (8)

Country Link
EP (1) EP0551291A1 (fi)
JP (1) JPH06500108A (fi)
CA (1) CA2088777A1 (fi)
FI (1) FI931071A0 (fi)
GB (1) GB9019833D0 (fi)
IE (1) IE913167A1 (fi)
PT (1) PT98902A (fi)
WO (1) WO1992004349A1 (fi)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2746310B1 (fr) 1996-03-22 1998-06-12 Oreal Compositions de teinture des fibres keratiniques contenant des pyrazolin-3,5-dione ; leur utilisation pour la teinture comme coupleurs, procede de teinture
FR2746309B1 (fr) 1996-03-22 1998-04-17 Oreal Composition de teinture des fibres keratiniques contenant des pyrazolopyrimidineoxo ; leur utilisation pour la teinture comme coupleurs, procedes de teinture
FR2746307B1 (fr) 1996-03-22 1998-04-30 Oreal Compositions de teinture des fibres keratiniques contenant des pyrrolo-azoles ; utilisation comme coupleurs ; procede de teinture
FR2746308B1 (fr) * 1996-03-22 1998-04-30 Oreal Compositions de teinture des fibres keratiniques contenant des imidazolo-azoles ; leur utilisation en teinture comme coupleurs ; procede de teinture
FR2746306B1 (fr) * 1996-03-22 1998-04-30 Oreal Compositions de teinture des fibres keratiniques contenant des pyrazolo-azoles ; leur utilisation pour la teinture comme coupleurs, procede de teinture
FR2746391B1 (fr) 1996-03-22 1998-04-17 Oreal Compositions cosmetiques a base de pyrazolin-4,5-diones, nouvelles pyrazolin-4,5 diones, procedes de preparation et utilisations

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3435972A1 (de) * 1984-10-01 1986-04-10 Boehringer Ingelheim KG, 6507 Ingelheim Diazepine enthaltende pharmazeutische zusammensetzungen mit paf-antagonistischer wirkung
ES2052172T3 (es) * 1989-03-23 1994-07-01 Pfizer Agentes antialergicos basados en diazepina.

Also Published As

Publication number Publication date
FI931071A (fi) 1993-03-10
JPH06500108A (ja) 1994-01-06
FI931071A0 (fi) 1993-03-10
EP0551291A1 (en) 1993-07-21
WO1992004349A1 (en) 1992-03-19
PT98902A (pt) 1992-07-31
GB9019833D0 (en) 1990-10-24
CA2088777A1 (en) 1992-03-12

Similar Documents

Publication Publication Date Title
JP4015176B2 (ja) 高血圧症の治療に有用な５，７−ジアミノピラゾロ４，３−ジピリミジン類
US5250531A (en) Dihydropyrimidine antiallergy agents
EP0389189B1 (en) Diazepine antiallergy agents
IL98316A (en) 2-Tauril-5-Transformed-1,2, 4-Triazolo] A-1,5 [] 1,3,5 [Triazine-7 Amines and 7-Troaril-2-Transformed Pirazolo] A-1,5 [] 1, 3,5 [triazine-4 amines process to prepare
EP0294074B1 (en) Dihydropyridine anti-allergic and anti-inflammatory agents
EP0299727B1 (en) Therapeutic agents
US5248681A (en) Dihydropyridine antiallergy agents
EP0266989B1 (en) Dihydropyridine anti-allergic and anti-inflammatory agents
EP0310386A2 (en) 4-Aryl-5-carbamoyl-1,4-dihydropyridines
EP0330327A2 (en) Dihydropyridines, their preparation and their use as PAF-antagonists
IE913167A1 (en) Therapeutic agents
EP0549598A1 (en) 2-METHYLIMIDAZO[4,5-c]PYRIDINE DERIVATIVES AND THERAPEUTIC AGENTS
EP0329357B1 (en) Dihydropyridine anti-allergic and anti-inflammatory agents
EP0462986B1 (en) Imidazopyrimidine antiallergy agents
US4963560A (en) 1,4-dihydropyridine derivatives
IE913102A1 (en) Therapeutic agents
US5214044A (en) 1,4-dihydropyridines useful as pharmaceuticals
PL165358B1 (pl) Sposób wytwarzania nowego 5-[4-(2-metyloimidazo[4,3-c]pirydylo-1)fenylo]-1,8-dwumetylo-3-(pirydylo-3)-1, 6 , 7, 8 -tetrahydropirazolo[3,4-b][1,4]-diazepinonu-7 PL